NOAH Compendium

Printed from NOAH Compendium (https://www.noahcompendium.co.uk). (c) Copyright NOAH Compendium 2024. All Rights Reserved.
Date: Friday, March 29, 2024 14:27

Release 2.88
Porcilis® M Hyo ID ONCE emulsion for injection for pigs (GB)
Species: Pigs
Therapeutic indication: Immunological veterinary medical products: For pigs
Active ingredient: Vaccine Antigens
Product:Porcilis® M Hyo ID ONCE emulsion for injection for pigs (GB)
Product index: Porcilis® M Hyo ID ONCE (GB)
Pig - meat: Zero days
Incorporating:
Qualitative and quantitative composition
Each dose of 0.2 ml contains:
Active substance:
Mycoplasma hyopneumoniae inactivated strain 11: ≥ 6.5 log2 Ab titre*
* Mean antibody titre (Ab) obtained after inoculation of mice with a 1/1,000 pig dose.
Adjuvants:
light liquid paraffin 34.6 mg
dl-α-tocopheryl acetate 2.5 mg
Excipients:
For the full list of excipients, see section “Pharmaceutical Particulars”.
Pharmaceutical form
Emulsion for injection.
White to nearly white emulsion with creamy appearance after shaking.
Clinical particulars
Target species
Pigs.
Indications for use
For the active immunisation of finishing pigs to reduce pulmonary lesions and the decrease in daily weight gain during the finishing period due to infection caused by Mycoplasma hyopneumoniae.
Onset of immunity: 3 weeks after vaccination.
Duration of immunity: 22 weeks after vaccination.
Contraindications
None.
Special warnings for each target species
Vaccinate healthy animals only.
Special precautions for use
Not applicable.
Operator warnings
To the user:
This veterinary medicinal product contains mineral oil. Accidental injection/self-injection may result in severe pain and swelling, particularly if injected into a joint or finger, and in rare cases could result in the loss of the affected finger if prompt medical attention is not given. If you are accidentally injected with this veterinary medicinal product, seek prompt medical advice even if only a very small amount is injected and take the package leaflet with you. If pain persists for more than 12 hours after medical examination, seek medical advice again.
To the physician:
This veterinary medicinal product contains mineral oil. Even if small amounts have been injected, accidental injection with this veterinary medicinal product can cause intense swelling, which may, for example, result in ischaemic necrosis and even the loss of a digit. Expert, PROMPT, surgical attention is required and may necessitate early incision and irrigation of the injected area, especially where there is involvement of finger pulp or tendon.
Adverse reactions
Pigs:
Very common
(> 1 animal / 10 animals treated):
Elevated temperature1, injection site swelling2
Uncommon
(1 to 10 animals / 1,000 animals treated):
Lying down, malaise
1 A transient elevated temperature (mean 0.7 °C, in individual pigs up to 2 °C) very commonly occurs on the day of vaccination. The animals return to normal 1 to 2 days after the peak temperature is observed.
2 A transient injection site swelling mostly consisting of hard non-painful button-like swellings of a diameter of up to 4 cm can be very commonly observed. In individual pigs redness and/or a biphasic pattern of the injection site swelling, consisting of an increase and decrease followed by another increase and decrease of the size, may be observed. The injection site swelling disappears completely within approximately 7 weeks after vaccination.
Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or its local representative or the national competent authority via the national reporting system. See also the package leaflet for respective contact details.
Use during pregnancy or lactation
Not applicable.
Interactions
Safety and efficacy data are available in pigs from 3 weeks of age onwards which demonstrate that this vaccine can be administered on the same day, but non-mixed with Porcilis PRRS (intradermal route) and/or non-mixed with Porcilis PCV ID or with Porcilis PCV ID mixed with Porcilis Lawsonia ID providing that non-mixed administration sites of vaccines are separated by at least 3 cm. Adverse events are as described in section 4.6, except for injection site swelling where a maximum size of up to 6 cm may occur in individual pigs. Injection site swellings may last 8 weeks and are very commonly accompanied by redness and crusts. In the event that the crust is rubbed off, some small skin damage may be commonly observed.
The product information of Porcilis PCV ID, Porcilis Lawsonia ID and Porcilis PRRS should be consulted before administration.
No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product except the products mentioned above. A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case-by-case basis.
Amounts to be administered and administration route
Intradermal use.
Intradermal administration of 0.2 ml per animal preferably at the sides of the neck or along the muscles of the back using an multi-dose needle-free injection device for intradermal application of liquids suitable to deliver a “jet-stream” volume of vaccine (0.2 ml ± 10%) through the epidermal layers of the skin. A small, transient, intradermal lump observed after the intradermal application is indicative of the appropriate vaccination technique.
Safety and efficacy of Porcilis M Hyo ID ONCE have been demonstrated using the device IDAL.
Vaccination scheme:
Vaccinate once from an age of 2 weeks onwards.
Before using the vaccine allow it to reach room temperature (15–25 °C) and shake well before use.
Avoid introduction of contamination.
Overdose
No adverse reactions other than those mentioned under section ‘‘interactions’’ have been observed after administration of a double dose. However, these reactions may be more pronounced. A mean transient temperature increase of 1 °C may be observed. Local reactions may be observed with a maximum diameter of up to 7 cm. The local reactions disappear completely within approximately 9 weeks after vaccination.
Withdrawal period
Zero days.
Pharmacological particulars
ATCvet code: QI09AB13.
Pharmacotherapeutic group
Immunologicals for Suidae; inactivated bacterial vaccines for pigs.
The veterinary medicinal product is an inactivated bacterial vaccine containing whole cell concentrate of Mycoplasma hyopneumoniae strain 11. This antigen is incorporated in an adjuvant based on a combination of light liquid paraffin and dl-α- tocopheryl acetate in order to give a prolonged stimulation of immunity. The product stimulates the development of active immunity in pigs against Mycoplasma hyopneumoniae.
Pharmaceutical particulars
Excipients
Polysorbate 80
Simethicone
Disodium phosphate dihydrate
Sodium dihydrogen phosphate dihydrate
Water for injections.
Major incompatibilities
Do not mix with any other veterinary medicinal product.
Shelf life
Shelf life of the veterinary medical product as packaged for sale: 2 years.
Shelf life after first opening the immediate packaging: 3 hours.
Special precautions for storage
Store in a refrigerator (2 °C – 8 °C).
It has been demonstrated that transport at 30 °C for 3 days has no impact on the quality of the product. Do not freeze.
Protect from direct sunlight.
Immediate packaging
Cardboard box with 1 glass vial of 10 ml (50 doses)
Cardboard box with 1 glass vial of 20 ml (100 doses)
Cardboard box with 5 glass vials of 10 ml (50 doses)
Cardboard box with 5 glass vials of 20 ml (100 doses)
Cardboard box with 10 glass vials of 10 ml (50 doses)
Cardboard box with 10 glass vials of 20 ml (100 doses)
Cardboard box with 1 PET vial of 20 ml (100 doses)
Cardboard box with 5 PET vials of 20 ml (100 doses)
Cardboard box with 10 PET vials of 20 ml (100 doses)
Vials are closed with a nitrile rubber stopper (type I, Ph. Eur.) and sealed with a coded aluminium cap.
Not all pack sizes may be marketed.
Disposal
Medicines should not be disposed of via wastewater.
Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal product should be disposed of in accordance with local requirements.
Marketing Authorisation Number
UK(GB): Vm 01708/5075
Significant changes
Date of the first authorisation or date of renewal
24 January 2012.
Date of revision of the text
September 2023
Any other information
For animal treatment only. Keep out of the sight and reach of children.
Legal category
Legal category: POM-V
GTIN
GTIN description:Porcilis M Hyo ID Once 1x50ds:
GTIN:08713184114785,
GTIN description:Porcilis M Hyo ID Once 1x100ds:
GTIN:08713184114792